Avenue Therapeutics Inc. (NASDAQ:ATXI) shares traded over 29.00% higher in trading on Thursday after providing regulatory update for IV Tramadol. The consensus recommendation for the company is moderate buy.
Shares of Phunware Inc. (PHUN) are 26.44% higher in trading this morning. Ascendiant Capital Markets issued a Buy recommendation for Phunware Inc. with a target price of $4.
Takung Art Co. Ltd. (AMEX:TKAT) is 43.39% higher at $1.81. It recently closed at $1.81, fluctuating in a day’s range from $1.25 to $1.30 and a 52-week trading range of $0.40 to $2.38.
PainReform Ltd. (NASDAQ:PRFX) is trading at $6.36 up with 44.60 percent or 1.96 point in trading today. It recently closed at $6.36, fluctuating in a day’s range from $4.3029 to $4.56.
Jupiter Wellness Inc. (NASDAQ:JUPW) was moving 32.33% higher in trading for Thursday, December 17, following an announcement from the firm that it will exhibit at SURF EXPO 2021, January 6-8, at the Orange County Convention Center in Orlando, Florida Booth #709.
Vivos Therapeutics Inc. (VVOS)’s shares were 28.37% higher in current market trading. The company recently revealed the closing of its initial public offering of 4,025,000 shares of its common stock.
Seneca Biopharma Inc. (NASDAQ:SNCA) is 21.72% higher at $0.94 during Thursday’s regular session after announcing a definitive agreement with Leading BioSciences under which a wholly owned subsidiary of Seneca will merge with LBS in an all-stock transaction. It last finished at $0.94, fluctuating in a day’s range from $0.74 to $0.82.
Vision Marine Technologies Inc. (NASDAQ:VMAR) is trading at $14.10 up with 18.39 percent or 2.19 point in market trading today after revealing a partnership with Gateway Investor Relations to manage its expanded IR program initiatives. It recently closed at $14.10, fluctuating in a day’s range from $11.5363 to $12.15.
XpresSpa Group Inc. (NASDAQ:XSPA) shares traded over 22.76% higher in trading on Thursday following its declaration of agreement with United Airlines for COVID-19 testing with XpresCheck testing facilities.
Shares of Evolus Inc. (NASDAQ:EOLS) are 18.75% higher in current session after reporting that the United States International Trade Commission (ITC) has issued its final determination in the action brought by Allergan and Medytox against Daewoong and Evolus.
Humanigen Inc. (NASDAQ:HGEN) was moving 18.78% higher in trading for Thursday, December 17. The firm today declared completing enrollment in its Phase 1 bioimaging study of ifabotuzumab in patients with recurrent glioblastoma multiforme (GBM). Cantor Fitzgerald issued an Overweight recommendation for Humanigen Inc..